InTandem Capital Partners has hired Lazard to advise on a continuation vehicle (CV) for portfolio company Ivy Fertility, according to three sources familiar with the matter.
This news service reported in August that InTandem was considering a CV process for the San Diego-based reproductive services group, having previously retained Harris Williams at the start of this year to advise on a potential sale effort. The sponsor planned to bring Ivy Fertility to market in 2025 after gauging buyer interest, but never launched a formal sale process, as reported.
Related articles
Press ReleaseSeptember 16, 2026
ASSA ABLOY
ASSA ABLOY acquires PACLOCK in the US
September 16, 2026
Press ReleaseSeptember 16, 2026
MySize
MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
September 16, 2026
Press ReleaseSeptember 16, 2026
Xpansiv
Xpansiv to Acquire Formbay, Australia's AI-Enabled Renewable Energy Certificate and Compliance Technology Platform
September 16, 2026
← Back to all articles
Generated by Olivia 6